HSA — authorised 7 December 2001
- Marketing authorisation holder: MYLAN IRELAND LTD
- Status: likely_approved
HSA authorised Arixtra on 7 December 2001
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 7 December 2001.
MYLAN IRELAND LTD holds the Singaporean marketing authorisation.